74: TRANSCRiPT: a study to assess Tarceva® in NSCLC with epidermal growth factor receptor mutations. (January 2015) - Lewanski, C.; Hennig, I.M.; Muthukumar, D.M.; Benepal, T.; Tahir, S.; Garcia, A.; Summerhayes, M.; De Queiros, S.K.